Methods for urine drug testing using one-step dilution and direct injection in combination with LC-MS/MS and LC-HRMS

Bioanalysis

Volumn 6, Issue 17, 2014, Pages 2229-2244

  Beck, Olof ^a   Ericsson, Magnus ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; BENZOYLECGONINE; BUPRENORPHINE; CENTRAL STIMULANT AGENT; COCAINE; CORTICOSTEROID; DESIGNER DRUG; DIURETIC AGENT; DRUG METABOLITE; EPHEDRINE; ETHYL GLUCURONIDE; GLUCURONIDE; HYDROXYBUTYRIC ACID; MESCALINE; METHYLPHENIDATE; MORPHINE; NARCOTIC AGENT; NICOTINE; OPIATE; PSYCHOTROPIC AGENT;

ANALYTIC METHOD; DILUTION; DIRECT INJECTION; DOPING; DRUG SCREENING; HUMAN; INJECTION; INVESTIGATIVE PROCEDURES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; ONE STEP DILUTION; PARTICLE SIZE; PUBLICATION; REVIEW; STANDARD; TANDEM MASS SPECTROMETRY; TOXICOLOGY; URINALYSIS; INDICATOR DILUTION CURVE; PROCEDURES; SUBSTANCE ABUSE;

CHROMATOGRAPHY, LIQUID; HUMANS; INDICATOR DILUTION TECHNIQUES; INJECTIONS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 84924765338     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.192     Document Type: Review

References (89)

1. Eskridge KD, Guthrie SK. Clinical issues associated with urine testing of substances of abuse. Pharmacotherapy 17, 497-510 (1997
2. Peat MA. Analytical and technical aspects of testing for drug abuse: confirmatory procedures. Clin. Chem. 34, 471-473 (1988
3. Schwartz RH. Urine testing in the detection of drugs of abuse. Arch. Intern. Med. 148, 2407-2412 (1988
4. Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA. Designer drugs: a medicinal chemistry perspective. Ann. NY Acad. Sci. 48, 18-38 (2012
5. Smith RD, Loo JA, Edmonds CG, Barinaga CJ, Udseth HR. New developments in biochemical mass spectrometry: electrospray ionization. Anal. Chem. 62, 882-899 (1990
6. Bowers LD. High-performance liquid chromatography/mass spectrometry: state of the art for the drug analysis laboratory. Clin. Chem. 35, 1282-1287 (1989
7. Xu RN, Fan L, Rieser MJ, El-Shourbagy TA. Recent advances in high-Throughput quantitative bioanalysis by LC- MS/MS. J. Pharm. Biomed. Anal. 44, 342-355 (2007
8. Mullet WM. Determination of drugs in biological fluids by direct injection of samples for liquid-chromatographic analysis. J. Biochem. Biophys. Methods 70, 263-273 (2007
9. Boyaci E, Gorynski K, Rodriguez-Lafuente A, Bojko B, Pawliszyn J. Introduction of solid-phase microextraction as a high-Throughput sample preparation toll in laboratory analysis of prohibited substances. Anal. Chim. Acta 809, 69-81 (2014
10. Yanes EG, Lovett DP. High-Throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS. J. Chromatogr. B 909, 42-50 (2012
11. Otero-Fernandez M, Cocho JA, Tabernero MJ, Bermejo AM, Bermejo-Barrera P, Moreda-Pineiro A. Direct tandem mass spectrometry for the simultaneous assay of opioids cocoaine, and metabolites in dried urine spots. Anal. Chim. Acta 784, 25-32 (2013
12. Wissenbach DK, Meyer MR, Remane D, Philipp AA, Weber AA, Maurer HH. Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept. Anal. Bioanal. Chem. 400, 3481-3489 (2011
13. Tang L, Kebarle P. Dependence of ion intensity in electrospray mass spectrometry on the concentration of the analytes in the electrosprayed solution. Anal. Chem. 65, 3654-3668 (1993
14. Gosetti F, Mazzucco E, Zampieri D, Gennaro MC. Signal suppression/enhancement in high-performance liquid chromatography tandem mass spectrometry. J. Chromatogr. A 1217, 3929-3937 (2010
15. Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J. Chromatogr. B 877, 2198-2207 (2009
16. Peters FT, Remane D. Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology - a review. Anal. Bioanal. Chem. 403, 2155-2172 (2012
17. King R, Bonfiglio R, Fernandez-Metzler C, Miller-Stein C, Olah T. Mechanistic investigation of ionization suppression in electrospray ionization. J. Am. Soc. Mass Spectrom. 11, 942-950 (2000
18. Matuszewski BK, Constanzer ML. Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75, 3019-3030 (2003
19. Bouatra S, Aziat F, Mandal R et al. The human urine metabolome. PLoS One 8(9), e73076 (2013
20. Matuszewski BK. Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. J. Chromatogr. B 830, 293-300 (2006
21. Dams R, Huestis MA, Lambert WE, Murphy CM. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. J. Am. Soc. Mass Spectrom. 14, 1290-1294 (2003
22. Wood M, Laloup M, Samyn N et al. Simultaneous analysis of gamma-hydroxybutyric acid and its precursors in urine using liquid chromatography-Tandem mass spectrometry. J. Chromatogr. A 1056, 83-90 (2004
23. Gustavsson E, Andersson M, Stephanson N, Beck O. Validation of direct injection electrospray LC-MS/MS for confirmation of opiates in urine drug testing. J. Mass Spectrom. 42, 881-889 (2007
24. Andersson M, Gustavsson E, Stephanson N, Beck O. Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3, 4-methylenedioxyamphetamine and 3, 4-methylenedioxymethamphetamine in urine drug testing. J. Chromatog. B 861, 22-28 (2008
25. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-Tandem mass spectrometry. Clin. Biochem. 38, 328-334 (2005
26. Niessen WM. Progress in liquid chromatography-mass spectrometry instrumentation and its impact on high-Throughput screening. J. Chromatogr. A 1000, 413-436 (2003
27. Maurer HH. Liquid chromatography-mass spectrometry in forensic and clinical toxicology. J. Chromatogr. B 713, 3-25 (1998
28. Henion J, Brewer E, Rule G. Sample preparation for LC/MS/MS: knowing the basic requirements and the bid picture of an LC/MS system can ensure success in most instances. Anal. Chem. 70, 650A-656A (1998
29. Jeanville PM, Estape ES Needham SR, Cole MJ. Rapid confirmation/quantitation of cocaine and benzoylecgonine in urine utilizing high-performance liquid chromatography and tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 11, 247-263 (2000
30. Jeanville PM, Estape ES, Torres-Negron I, Marti A. Rapid confirmation/quantitation of ecgonine methyl ester, benzoylecgonine and cocaine in urine using on-line extraction coupled with fast HPLC and tandem mass spectrometry. J. Anal. Toxicol. 25, 69-75 (2001
31. Fitzgerald RL, Rivera JD, Herold DA. Broad spectrum drug identification directly from urine, using liquid chromatography-Tandem mass spectrometry. Clin. Chem. 45, 1224-1234 (1999
32. Dams R, Murphy CM, Lambert WE, Huestis MA. Urine drug testing for opioids, cocaine, and metabolites by direct injection liquid chromatography/tandem mass spectrometry. Rapid Comm. Mass Spectrom. 17, 1665-1670 (2003
33. Nordgren HK, Beck O. Direct screening of urine for MDMA and MDA by liquid chromatography-Tandem mass spectrometry. J. Anal. Toxicol. 27, 15-19 (2003
34. Kronstrand R, Selden TG, Josefsson M. Analysis of buprenorphine, nor buprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry. J. Anal. Toxicol. 27, 464-470 (2003
35. Eichhorst J, Etter M, Lepage J, Lehotay DC. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-Tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods. Clin. Biochem. 37, 175-183 (2004
36. Wurst FM, Kempter C, Seidl S, Alt A. Ethyl glucuronide - a marker of alcohol consumption and a relapse marker with clinical and forensic implications. Alcohol Alcohol. 34, 71-77 (1999
37. Stephanson N, Dahl H, Helander A, Beck O. Direct quantification of ethyl glucuronide in clinical urine samples by liquid chromatography-mass spectrometry. Ther. Drug Monitor. 24, 645-651 (2002
38. Weinmann W, Schaefer P, Thierauf A, Schreiber A, Wurst FM. Confirmatory analysis of ethylglucuronide in urine by liquid-chromatography/electrospray ionization/tandem mass spectrometry according to forensic guidelines. J. Am. Soc. Mass Spectrom. 15, 188-193 (2004
39. Helander A, Kenan N, Beck O. Comparison of analytical approaches for liquid chromatography/mass spectrometry determination of the alcohol biomarker ethyl glucuronide in urine. Rapid Comm. Mass Spectrom. 24, 1737-1743 (2010
40. Bicker W, Lämmerhofer M, Keller T, Schuhmacher R, Krska R, Linder W. Validated method for the determination of the ethanol consumption markers ethyl glucuronide, ethyl phosphate, and ethyl sulfate in human urine by reversed-phase/weak anion exchange liquid chromatography-Tandem mass spectrometry. Anal. Chem. 78, 5884-5892 (2006
41. Nordgren H, Beck O. Multicomponent screening for drugs of abuse. Direct analysis of urine by LC-MS-MS. Ther. Drug Monitor. 26, 90-97 (2004
42. Nordgren H, Holmgren P, Liljeberg P, Eriksson N, Beck O. Application of direct urine LC-MS-MS analysis screening of novel substances in drug abusers. J. Anal. Toxicol. 29, 234-238 (2005
43. Björnstad K, Helander A, Beck O. Development and clinical application of an LC-MS-MS method for mescaline in urine. J. Anal. Toxicol. 32, 227-231 (2008
44. Björnstad K, Beck O, Helander A. A multi-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine. J. Chromatogr. B 877, 1162-1169 (2009
45. Thörngren JO, Östervall F, Garle M. A high-Throughput multicomponent screening method for diuretics, masking agents, central nervous system (CNS) stimulants and opiates in human urine by UPLC-MS/MS. J. Mass Spectrom. 43, 980-992 (2008
46. Al-Saffar Y, Stephanson NN, Beck O. Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine - experience from the Swedish population. J. Chromatogr. B 930, 112-120 (2013
47. Helander A, Beck O, Hägerkvist R, Hultén P. Identification of novel psychoactive drug use in Sweden based on laboratory analysis - initial experiences from the STRIDA project. Scand. J. Clin. Lab. Invest. 73, 400-406 (2013
48. Helander A, Bäckberg M, Hultén P, Al-Saffar Y, Beck O. Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project. Forensic Sci. Int. 243C, 23-29 ( 2014
49. Johansen SS, Windberg CN. Simultaneous determination of ?-hydroxybutyrate (GHB) and its analogues (GBL, 1.4-BD, GVL) in whole blood and urine by liquid chromatography coupled to tandem mass spectrometry. J. Anal. Toxicol. 35, 8-14 (2011
50. Dahl SR, Olsen KM, Strand DH. Determination of gamma-hydroxybutyrate (GHB), beta-hydroxybutyrate (BHB), pregabalin, 1, 4butane-diol (1, 4BD) and gamma-butyrolactone (GBL) in whole blood and urine samples by UPLC-MSMS. J. Chromatogr. B 885-886, 37-42 (2012
51. Ingels ASME, Wille SMR, Samyn N, Lambert WE, Stove CP. Screening and confirmation methods for GHB determination in biological fluids. Ann. Bioanal. Chem. 406, 3553-3577 (2014
52. Bell C, George C, Kicman AT, Traynor A. Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs. Drug Test. Anal. 3, 496-504 (2011
53. Lynch KL, Breaud AR, Vandenberghe H, Wu AHB, Clarke W. Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening. Clin. Chim. Acta 411, 1474-1481 (2010
54. Dresen S, Ferreiros N, Gnann H, Zimmermann R, Weinmann W. Detection and identification of 700 drugs by multi-Target screening with a 3200 Q TRAP® LC-MS/MS system and library searching. Anal. Bioanal. Chem. 396, 2425-2434 (2010
55. Lee YW. Simultaneous screening of 177 drugs of abuse in urine using ultra-performance liquid chromatography with tandem mass spectrometry in drug-intoxicated patients. Clin. Psychopharm. Neurosci. 11, 158-164 (2013
56. Stone J. Broad spectrum drug screening using liquid chromatography-hybrid triple quadropole linear ion trap mass spectrometry. In: Clinical Applications of Mass Spectrometry. Garg U, Hammett-Stabler CA (Eds). Humana Press, USA, 203-218 (2010
57. Eichhorst JC, Etter ML, Rousseaux N, Lehotay DC. Drugs of abuse testing by tandem mass spectrometry: a rapid, simple method to replace immunoassays. Clin. Biochem. 42, 1531-1542 (2009
58. Saleh A, Stephanson NN, Granelli, I, Villen T, Beck O. Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-Time-of-flight mass spectrometry. J. Chromatogr. B 909, 6-13 (2012
59. Tsai IL, Weng TI, Tseng YJ, Tan HKL, Sun HJ, Kuo CH. Screening and confirmation of 62 drugs of abuse and metabolites in urine by ultra-high-performance liquid chromatography - quadrupole time-of-flight mass spectrometry. J. Anal. Toxicol. 37, 642-651 (2013
60. Crews BO, Pesce AJ, West R, Nguyen H, Fitzgerald RL. Evaluation of high-resolution mass spectrometry for urine toxicology screening in a pain management setting. J. Anal. Toxicol. 36, 601-607 (2012
61. Maralikova B, Weinmann W. Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-Tandem mass spectrometry with respect to criteria for compound identification. J. Chromatog. B 811, 21-30 (2004
62. European Union Decision 2002/657/EC. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ: L:2002:221:0008:0036:ES:PDF
63. US Department of Health and Human Services, Food and Drug Administration (FDA). Center for Veterinary Medicine, 1 May. Guidance for Industry. Mass Spectrometry for Confirmation of the Identity of Animal Drug Residues (FDA Guidance Document 118). www.fda.gov/../AnimalVeterinary/ GuidanceComplianceEnforcement/ GuidanceforIndustry/ ucm052658.pdf
64. World Anti-Doping Agency. WADA Technical Document TD2003IDCR. http://www.wada-ama.org/rtecontent/document/criteria12. pdf
65. Fitzgerald RL, Griffin TL, Yun YM, Godfrey RA, West R, Pesce AJ. Dilute and shoot: analysis of drugs of abuse using selected reaction monitoring for quantification and full scan product ion spectra for identification. J. Anal. Toxicol. 36, 106-111 (2012
66. Stephanson N, Josefsson M, Kronstrand R, Beck O. Accurate identification and quantification of 11-nor-delta9- tetrahydrocannabinol-9-carboxylic acid in urine drug testing: evaluation of a direct high efficiency liquid chromatographic-mass spectrometric method. J. Chromatog. B 871, 101-108 (2008
67. Chebbah C, Pozo OJ, Deventer K, Van Eenoo P, Delbeke FT. Direct quantification of 11-nor-delta9- tetrahydrocannabinol-9-carboxylic acid in urine by liquid chromatography/tandem mass spectrometry in relation to doping control analysis. Rapid Comm. Mass Spectrom. 24, 1133-1141 (2010
68. Felli M, Martello S, Chiarotti M. LC-MS-MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: application to workplace confirmation tests. Forensic Sci. Int. 204, 67-73 (2011
69. Karampela S, Vardakou I, Papoutsis I et al. Direct urine analysis for the identification and quantification of selected benzodiazepines for toxicology screening. J Chromatog. B 902, 42-46 (2012
70. Deventer K, Pozo OJ, Delbeke FT, Van Eenoo P. Direct quantification of morphine glucuronides and free morphine in urine by liquid chromatography-Tandem mass spectrometry. Forensic Toxicol. 30, 106-113 (2012
71. Andersson M, Stephanson N, Öhman I, Terzuoli T, Lindh JD, Beck O. Direct and efficient liquid chromatographic tandem mass spectrometric method for opiates in urine drug testing - importance of 6-acetylmporphine and reduction of analytes. Drug Test. Anal. 6(4), 317-324 (2014
72. Edinboro LE, Backer RC, Poklis A. Direct analysis of opiates in urine by liquid chromatography-Tandem mass spectrometry. J. Anal. Toxicol. 29, 704-710 (2005
73. Deventer K, Pozo OJ, Verstraete AG, Van Eenoo P. Dilute and shoot-liquid chromatography-mass spectrometry for urine analysis in doping control and analytical toxicology. Trends Analyt. Chem. 55, 1-13 (2014
74. WADA. Prohibited List 2014. World Anti-Doping Agency (WADA), Montreal, Canada (2013
75. WADA. Technical Document Minimum Required Performance Limits for Detect ion of Prohibited Substances: TD2013MRPL. World Anti-Doping Agency (WADA), Montreal, Canada (2013
76. Guddat S, Solymos E, Orlovius A et al. High-Throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-Tandem mass spectrometry multi-Target approach. Drug Test. Anal. 3, 836-850 (2011
77. Deventer K, Pozo OJ, Van Eenoo P, Delbeke FT. Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography-Tandem mass spectrometry. Comparison between liquid-liquid extraction and direct injection. J. Chromatog. A 1216, 5819-5827 (2009
78. Politi L, Morini L, Polettini A. A direct screening procedure for diuretics in human urine by liquid chromatography-Tandem mass spectrometry with information dependent acquisition. Clin. Chim. Acta 386, 46-52 (2007
79. Marclay F, Grata E, Perrenoud L, Saugy M. A one-year monitoring of nicotine use in sport: Frontier between potential performance enhancement and addiction issues. Forensic Sci. Int. 213 73-84 (2011
80. Deventer K, Pozo OJ, Van Eenoo P, Delbeke FT. Development and validation of an LC-MS/MS method for the quantification of ephedrines in urine. J. Chromatog. B 877, 369-374 (2009
81. Gray N, Musenga A, Cowan D, Plumb R, Smith N. A simple high pH liquid chromatography-Tandem mass spectrometry method for basic compounds: application to ephedrines in doping control. J. Chromatog. A 1218, 2098-2105 (2011
82. Spyridaki M-H, Kiousi P, Vonaparti A et al. Doping control analysis in human urine by liquid chromatography- electrospray ionization ion trap mass spectrometry for the Olympic Games Athens 2004: determination of corticosteroids and quantification of ephedrines, salbutamol and morphine. Anal. Chim. Acta 573-574, 242-249 (2006
83. Badoud F, Grataa E, Perrenoud L et al. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis. J. Chromatog. A 1216, 4423-4433 (2009
84. Girón A J, Deventer K, Roels K, Van Eenoo P. Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC-HRMS for doping control. Anal. Chim. Acta 721, 137-146 (2012
85. Peng J, Chen YT, Chen CL, Li L. Development of a universal metabolome-standard method for long-Term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery. Anal. Chem. 86(13), 6540-6547 (2014
86. Stokvis E, Rosing H, Beijnen JH. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?. Rapid Commun. Mass Spectrom. 19, 401-407 (2005
87. Wang S, Cyronak M, Yang E. Does a stable isotopically labeled internal standard always correct analyte response?. A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. J. Pharm. Biomed. Anal. 43, 701-707 (2007
88. Berg T, Strand DH. 13C labelled internal standards - a solution to minimize ion suppression effects in liquid chromatography-Tandem mass spectrometry analyses of drugs in biological samples?. J. Chromatogr. A 1218, 9366-9374 (2011
89. Berg T, Karlsen M, Oiestad AM, Johansen JE, Liu H, Strand DH. Evaluation of 13C- and 2H-labeled internal standards for the determination of amphetamines in biological samples, by reversed-phase ultra-high performance liquid chromatography-Tandem mass spectrometry. J. Chromatogr. A 1344, 83-90 (2014